MedTrace Logo

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

NCT04766853 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-10-24

No results posted yet for this study

Summary

This study is a prospective, randomized pilot study. To verify an efficacy and safety of the Intratympanic drug delivery vehicle, patients who have not responded to the existing standard treatment will be enrolled. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.

Conditions

  • Hearing Loss, Sudden
  • Hearing Loss, Ototoxic
  • Hearing Loss, Noise-Induced
  • Meniere Disease

Interventions

DRUG

Dexamethasone

Dexamethasone 5mg/ml

DRUG

Hyaluronic acid

Hyaluronic Acid 20mg/2ml

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-22
Primary Completion
2023-04-18
Completion
2024-07-19

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04766853 on ClinicalTrials.gov